Logo image of INVE

IDENTIV INC (INVE) Stock Fundamental Analysis

NASDAQ:INVE - Nasdaq - US45170X2053 - Common Stock - Currency: USD

3.2  -0.01 (-0.31%)

Fundamental Rating

4

Taking everything into account, INVE scores 4 out of 10 in our fundamental rating. INVE was compared to 124 industry peers in the Electronic Equipment, Instruments & Components industry. While INVE has a great health rating, there are worries on its profitability. While showing a medium growth rate, INVE is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

INVE had negative earnings in the past year.
In the past year INVE has reported a negative cash flow from operations.
In multiple years INVE reported negative net income over the last 5 years.
In multiple years INVE reported negative operating cash flow during the last 5 years.
INVE Yearly Net Income VS EBIT VS OCF VS FCFINVE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

With an excellent Return On Assets value of 45.30%, INVE belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
With an excellent Return On Equity value of 47.99%, INVE belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
ROA 45.3%
ROE 47.99%
ROIC N/A
ROA(3y)12.53%
ROA(5y)6.04%
ROE(3y)12.26%
ROE(5y)3.86%
ROIC(3y)N/A
ROIC(5y)N/A
INVE Yearly ROA, ROE, ROICINVE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

INVE's Profit Margin of 277.67% is amongst the best of the industry. INVE outperforms 100.00% of its industry peers.
In the last couple of years the Profit Margin of INVE has grown nicely.
The Gross Margin of INVE (1.28%) is worse than 88.80% of its industry peers.
INVE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 277.67%
GM 1.28%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y732.24%
PM growth 5YN/A
GM growth 3Y-67.07%
GM growth 5Y-50.69%
INVE Yearly Profit, Operating, Gross MarginsINVE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200

More info and screens

7

2. Health

2.1 Basic Checks

INVE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for INVE has been increased compared to 1 year ago.
The number of shares outstanding for INVE has been increased compared to 5 years ago.
INVE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
INVE Yearly Shares OutstandingINVE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
INVE Yearly Total Debt VS Total AssetsINVE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

An Altman-Z score of 2.69 indicates that INVE is not a great score, but indicates only limited risk for bankruptcy at the moment.
INVE has a Altman-Z score of 2.69. This is comparable to the rest of the industry: INVE outperforms 48.00% of its industry peers.
INVE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.69
ROIC/WACCN/A
WACC8.75%
INVE Yearly LT Debt VS Equity VS FCFINVE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

INVE has a Current Ratio of 19.20. This indicates that INVE is financially healthy and has no problem in meeting its short term obligations.
INVE has a Current ratio of 19.20. This is amongst the best in the industry. INVE outperforms 96.80% of its industry peers.
A Quick Ratio of 18.26 indicates that INVE has no problem at all paying its short term obligations.
INVE's Quick ratio of 18.26 is amongst the best of the industry. INVE outperforms 96.80% of its industry peers.
Industry RankSector Rank
Current Ratio 19.2
Quick Ratio 18.26
INVE Yearly Current Assets VS Current LiabilitesINVE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for INVE have decreased strongly by -278.57% in the last year.
INVE shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 438.90% yearly.
INVE shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -77.12%.
The Revenue for INVE have been decreasing by -20.49% on average. This is quite bad
EPS 1Y (TTM)-278.57%
EPS 3Y438.9%
EPS 5YN/A
EPS Q2Q%-125%
Revenue 1Y (TTM)-77.12%
Revenue growth 3Y-36.46%
Revenue growth 5Y-20.49%
Sales Q2Q%-76.89%

3.2 Future

The Earnings Per Share is expected to grow by 4.66% on average over the next years.
INVE is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 30.86% yearly.
EPS Next Y8.58%
EPS Next 2Y4.66%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-53.43%
Revenue Next 2Y-28.31%
Revenue Next 3Y40.96%
Revenue Next 5Y30.86%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
INVE Yearly Revenue VS EstimatesINVE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M
INVE Yearly EPS VS EstimatesINVE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -1 -2 -3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for INVE. In the last year negative earnings were reported.
Also next year INVE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
INVE Price Earnings VS Forward Price EarningsINVE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
INVE Per share dataINVE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.66%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

INVE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IDENTIV INC

NASDAQ:INVE (4/25/2025, 8:15:59 PM)

3.2

-0.01 (-0.31%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)03-05 2025-03-05/amc
Earnings (Next)05-07 2025-05-07/amc
Inst Owners53.05%
Inst Owner Change-80.04%
Ins Owners6.78%
Ins Owner Change0.12%
Market Cap75.26M
Analysts82.22
Price Target6.97 (117.81%)
Short Float %1.35%
Short Ratio4.13
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-10.27%
Min EPS beat(2)-58.98%
Max EPS beat(2)38.44%
EPS beat(4)1
Avg EPS beat(4)-24.15%
Min EPS beat(4)-58.98%
Max EPS beat(4)38.44%
EPS beat(8)2
Avg EPS beat(8)-59.87%
EPS beat(12)5
Avg EPS beat(12)-36.77%
EPS beat(16)8
Avg EPS beat(16)-45.77%
Revenue beat(2)2
Avg Revenue beat(2)7.48%
Min Revenue beat(2)7.34%
Max Revenue beat(2)7.63%
Revenue beat(4)2
Avg Revenue beat(4)2.56%
Min Revenue beat(4)-4.12%
Max Revenue beat(4)7.63%
Revenue beat(8)2
Avg Revenue beat(8)-1.12%
Revenue beat(12)3
Avg Revenue beat(12)-2.63%
Revenue beat(16)4
Avg Revenue beat(16)-2.14%
PT rev (1m)-4.65%
PT rev (3m)-4.65%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.04%
EPS NY rev (1m)0%
EPS NY rev (3m)3.06%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.71%
Revenue NY rev (1m)-4.23%
Revenue NY rev (3m)-4.23%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.83
P/FCF N/A
P/OCF N/A
P/B 0.49
P/tB 0.49
EV/EBITDA N/A
EPS(TTM)-1.06
EYN/A
EPS(NY)-0.97
Fwd EYN/A
FCF(TTM)-0.72
FCFYN/A
OCF(TTM)-0.66
OCFYN/A
SpS1.13
BVpS6.55
TBVpS6.55
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 45.3%
ROE 47.99%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 277.67%
GM 1.28%
FCFM N/A
ROA(3y)12.53%
ROA(5y)6.04%
ROE(3y)12.26%
ROE(5y)3.86%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y732.24%
PM growth 5YN/A
GM growth 3Y-67.07%
GM growth 5Y-50.69%
F-Score5
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 52.02%
Cap/Sales 5.61%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 19.2
Quick Ratio 18.26
Altman-Z 2.69
F-Score5
WACC8.75%
ROIC/WACCN/A
Cap/Depr(3y)126.88%
Cap/Depr(5y)106.77%
Cap/Sales(3y)6.31%
Cap/Sales(5y)4.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-278.57%
EPS 3Y438.9%
EPS 5YN/A
EPS Q2Q%-125%
EPS Next Y8.58%
EPS Next 2Y4.66%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-77.12%
Revenue growth 3Y-36.46%
Revenue growth 5Y-20.49%
Sales Q2Q%-76.89%
Revenue Next Year-53.43%
Revenue Next 2Y-28.31%
Revenue Next 3Y40.96%
Revenue Next 5Y30.86%
EBIT growth 1Y-530.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year17.18%
EBIT Next 3Y45.38%
EBIT Next 5Y33.76%
FCF growth 1Y-441.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1433.88%
OCF growth 3YN/A
OCF growth 5YN/A